Profile | GDS2987 / GI_18375521-A |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 3.3 | 12 |
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | 21.8 | 56 |
GSM215254 | HMVEC_atorvastatin_rep1 | 10 | 27 |
GSM215282 | HMVEC_atorvastatin_rep3 | ||
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 34.9 | 55 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 4 | 8 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 37.8 | 52 |
GSM215294 | HMVEC_SLx2119_rep1 | 5.4 | 20 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | 18.1 | 28 |
GSM215298 | PASMC_vehicle_rep2 | 31.7 | 44 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 31.6 | 48 |
GSM215312 | PASMC_atorvastatin_rep2 | 52 | 61 |
GSM215313 | PASMC_atorvastatin_rep3 | 10.2 | 16 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 49.6 | 64 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | 8.4 | 15 |
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | 2.4 | 5 |
GSM215330 | Fibroblasts_vehicle_rep1 | 1597.9 | 97 |
GSM215331 | Fibroblasts_vehicle_rep2 | 1772.1 | 97 |
GSM215332 | Fibroblasts_vehicle_rep3 | 1640.6 | 97 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 1004.5 | 95 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 1151.5 | 95 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 1069.8 | 95 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 1605.2 | 97 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 1477.1 | 96 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 1578.4 | 96 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 1330.8 | 96 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 1190.2 | 95 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 1165.9 | 95 |